Clinical characteristics of patients and controls, such as gender, antidiabetic and antilipid treatments, smoking history, and obesity conditions, may also have influence on altered BDNF levels (Table 1). The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.